Integrated Annual Report

Overview

The report describes FY2025-26 as a year of 17% consolidated revenue growth to `271.5 billion and expansion into MedTech through Amplitude Surgical. It also highlights new biosimilar and rare-disease launches and continued R&D investment. On sustainability, it reports a 42% renewable-energy share and a 5% year-on-year reduction in GHG intensity.

Document

Report type: Integrated Report
Class: Embedded
Scope: Full report
Fiscal year: 2025-2026
Period: 1 April 2025 – 31 March 2026
Publication date: 10 July 2026
Language: English
Pages
File size
Restatement: Disclosed

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Ratings

GRI level

Materiality

Assessment
Basis

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services